NK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis
Clinical trial NCT06676631 · RECRUITING
Trial details
- NCT number
- NCT06676631
- Sponsor
- Guangdong Provincial People's Hospital
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-19
- Primary completion
- 2026-12-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.